At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major issue is individualising treatment to each patient, as response varies greatly between different patients. The challenge is to understand how and which patients will respond to therapies. New drugs are currently on the horizon, which will offer new and better solutions to patients.
1. What have been the most significant recent developments in the area of DME? (1:02)
2. Discuss the current unmet needs and/or the challenges you face when treating patients with DME. (2:00)
3. What developments are you most excited about in the area of DME over the next few years? (3:20)